Chlamydia screening drops after change in cervical cancer screening guideline

July 11, 2017, American Academy of Family Physicians

A 2012 cervical cancer screening guideline change is associated with reduced testing for cervical cancer and chlamydia and reduced identification of chlamydia cases in young women. Screening for chlamydia, the most commonly-diagnosed bacterial sexually transmitted infection worldwide, is often conducted with cervical cancer screening.

Using population-based physician billing claims data and data, researchers in Ontario, Canada assessed the population-level impacts of new screening guidelines recommending less frequent screening and older age of screening initiation.

They found that Pap testing declined in all age groups following the guideline release, with the greatest relative reductions observed for females aged 15 to 19 years. The guideline change was also followed by a decrease in testing in females aged 15 to 29 years. The largest reduction was observed in the 15 to 19-year age group (relative reduction of 26 percent), in whom cervical cancer screening is no longer recommended, suggesting that reduced chlamydia testing may have been an unintended consequence of the guideline change.

Reduced chlamydia testing coincided with a reduction in reported chlamydia incidence in females aged 15 to 19 years and 20 to 24 years (relative reductions of 17 percent and 14 percent, respectively). In contrast, there were small increases in in males aged 20 to 24 years and 25 to 29 years two years after the guideline change. Incidence rates were unchanged for males.

The authors call for separating screening recommendations for from recommendations for cervical cancer and highlight the need to promote chlamydia screening strategies for females that can be adopted into routine clinical care.

Explore further: Current performance measures for cervical cancer screening promote overscreening

More information: Annals of Family Medicine, www.annfammed.org/content/15/4/329

Related Stories

Current performance measures for cervical cancer screening promote overscreening

July 10, 2017
Following current performance measures that require adherence to strict time intervals for cervical cancer screening may promote overscreening. Changing cervical cancer screening performance measures to distinguish between ...

How have HPV vaccines affected cervical cancer screening?

June 7, 2017
A new review looks at cervical cancer screening in the era of HPV vaccination. The review notes that trials have demonstrated the efficacy and safety of vaccines against HPV infection, but the complete effect of HPV vaccination ...

Screening, HPV vaccine can prevent cervical cancer: FDA

February 8, 2017
(HealthDay)—Women can reduce their risk of cervical cancer through vaccination and screening, the U.S. Food and Drug Administration says.

Chlamydia screening for pregnant young women prevents newborn complications, while saving health dollars

August 26, 2015
Chlamydia screening for all pregnant women aged between16 and 25 is cost-effective and can prevent harm to babies, a University of Melbourne study has found.

ACOG: New recommendations for cervical cancer screening

December 23, 2015
(HealthDay)—In a practice bulletin published in the January issue of Obstetrics & Gynecology, new recommendations are presented for cervical cancer screening and prevention.

New Pap smear schedule led to fewer chlamydia tests, new study suggests

July 20, 2015
It's a tale of two tests: one for early signs of cervical cancer, the other for a sexually transmitted disease. But a new study suggests that a change in the recommended schedule for one may have dramatically lowered the ...

Recommended for you

A new approach to developing a vaccine against vivax malaria

September 21, 2018
A novel study reports an innovative approach for developing a vaccine against Plasmodium vivax, the most prevalent human malaria parasite outside sub-Saharan Africa. The study led by Hernando A. del Portillo and Carmen Fernandez-Becerra, ...

Pre-clinical success for a universal flu vaccine offers hope for third generation approach

September 21, 2018
Researchers from the University of Oxford's Department of Zoology have demonstrated pre-clinical success for a universal flu vaccine in a new paper published in Nature Communications.

Researchers define possible molecular pathway for neurodegeneration in prion diseases

September 21, 2018
A new study has shed light on the mechanisms underlying the progression of prion diseases and identified a potential target for treatment.

Fighting a deadly parasite: Scientists devise a method to store Cryptosporidium, aiding vaccine research efforts

September 21, 2018
In May, just before one of the hottest summers on record, the U.S. Centers for Disease Control and Prevention issued a warning about diseases lurking in recreational water facilities like swimming pools and water playgrounds. ...

Scientists make significant discovery in the fight against drug-resistant tuberculosis

September 20, 2018
A team of scientists have identified a naturally occurring antibiotic that may help in the fight against drug-resistant Tuberculosis.

Anti-cancer drugs may hold key to overcoming antimalarial drug resistance

September 20, 2018
Scientists have found a way to boost the efficacy of the world's most powerful antimalarial drug with the help of chemotherapy medicines, according to new research published in the journal Nature Communications.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.